In another study, bortezomib-resistant U266 MM cells were shown to have increased numbers of mitochondria and elevated levels of the mitochondrial biogenesis markers PGC1α and the NAD-dependent deacetylase sirtuin 1 (SIRT1) [287]. This evidence concerns the gene PPARGC1A and Miyoshi myopathy.